Calcium and Glutathione: Comparison
View Latest Version
Please note this is a comparison between Version 2 by Jason Zhu and Version 1 by Jeffrey Ram.

Extracellular glutathione (GSH) and oxidized glutathione (GSSG) can modulate the function of the extracellular calcium sensing receptor (CaSR). The CaSR has a binding pocket in the extracellular domain of CaSR large enough to bind either GSH or GSSG, as well as the derivatives L-cysteine glutathione disulfide (CySSG) and the compound cysteinyl glutathione (CysGSH). CySSG occurs naturally in the circulation and may be the preferred ligand for modulation of CaSR.

  • calcium-sensing receptor
  • L-cysteine-glutathione disulfide
  • glutathione
  • Ca

1. Introduction

Associations of calcium (Ca) and glutathione in various organs are not well understood. However, molecular modeling by Wang et al. [1] identified a glutathione binding site on the extracellular calcium sensing receptor (CaSR) and demonstrated glutathione-elicited changes in extracellular calcium responses mediated by CaSR transfected into a model cell system. With the perspective of more recent crystallographic studies of CaSR [2,3,4,5][2][3][4][5] and docking studies of various glutathionergic ligands with CaSR, this paper explores the potential actions that circulating glutathionergic compounds (reduced glutathione (GSH, PubChem CID 124886); oxidized glutathione (GSSG, PubChem CID 65359); and another circulating oxidized derivative of glutathione, L-cysteine-glutathione disulfide (CySSG, PubChem CID 10455148) may have that could be mediated via binding to the extracellular domain of CaSR. 

1.1. GSH Synthesis and Relationship to GSH-Derivatives

GSH is a tripeptide (gamma-glutamyl-cysteinyl-glycine) made by non-ribosomal mechanisms. The rate-limiting enzyme in GSH synthesis is glutamate-cysteine ligase (GCL, EC 6.3.2.2), whose activity is limited by the amount of enzyme and the availability of cysteine. Glutathione synthase (GSS) couples glycine to the resultant gamma-glu-cys to make GSH. GSH reacts with oxidants via glutathione peroxidase (GPx) to form GSSG, form GS- adducts with various electrophiles (these are often toxicants that are thereby detoxified) via glustathione-S-transferases (GSTs), or glutathionylates proteins through reactions mediated by glutaredoxins and thioredoxins. Alternatively, GSH is transported out of cells where it can undergo further reactions. GSH can be resynthesized from GSSG by the actions of glutathione disulfide reductase (GR).
CySSG can be formed intracellularly or extracellularly by thiol-disulfide exchange with cystine [6], either spontaneously or via enzymatic catalysis by a thioltransferase [7,8][7][8]. CySSG is also produced spontaneously by the reaction of GSSG and cysteine [6]; gamma-glutamyltransferase (GGT) produces CySSG and cystine from GSSG, a reaction that can be inhibited by AT-125 (Acivicin) [9]. GGT also degrades CySSG, which can also be inhibited by Acivicin [9]. All three forms of glutathione are found in mammalian circulation [10,11,12,13,14,15][10][11][12][13][14][15].
Plasma GSH and CySSG are usually in the 1–10 µM range, while GSSG is often 1 µM or less [10,15][10][15]. Many studies have used enzymatic methods to measure GSH; “oxidized glutathione” is often also measured after reduction of oxidized forms to GSH; however, this method does not distinguish between the two oxidized forms of glutathione. Measurement of both oxidized forms of glutathione requires HPLC, which can distinguish between CySSG and GSSG. In healthy people over a broad age range, plasma levels of GSH and CySSG are correlated (Pearson correlation coefficient = 0.622, p < 0.001 [10]). Plasma redox pairs have different Eh values (GSH/GSSG, −140 mV; Cys/CySS, −72 mV; and Cys-GSH/CySSG, −110 mV; [10]), indicating that relative concentrations of the reactants have different chemical potentials and are not at redox equilibrium in circulation. CySSG is also found in non-mammalian species, most notably in the polychaete Nereis succinea where it functions as a spawning pheromone [16,17,18,19][16][17][18][19].

1.2. CaSR Function in Parathyroid, Kidney, and Other Tissues

CaSR was first identified in parathyroid gland, where it solved the long-standing problem of what receptor mediated up- and down-regulation of parathyroid hormone (PTH) synthesis and release by Ca [20]. Unlike most secretory processes, PTH release is decreased by increases of extracellular Ca. CaSR was discovered to be a G-protein-coupled receptor that mediates responses in parathyroid cells by activating Gq, which regulates phospholipase C (PLC), and Gi, which inhibits cAMP synthesis (as reviewed by Ward [21]). CaSR activity is affected by small changes in Ca in the physiological extracellular range (1–10 mM) [20], and its sensitivity can be shifted by various agents, such as amino acids [22].
CaSR is found in many other tissues. In kidney, CaSR expression is particularly high in thick ascending limb (TAL) [21] but also occurs in many renal tissues, including proximal tubule, collecting duct, and juxtaglomerular apparatus [23]. Although approximately 65% of filtered Ca is reabsorbed in the proximal tubule, the proximal reabsorption is mostly not subject to regulatory control. Ca reabsorption in TAL and distal convoluted tubule is regulated in part by CaSR, coupled via G-protein mechanisms to cellular responses. The effect of these actions is to decrease cAMP, which would inhibit the luminal membrane cAMP-dependent Na-K-Cl cotransporter [24,25,26][24][25][26], thereby decreasing Na-reabsorption and inhibiting luminal (apical) K channels via phospholipase A2 and P-450 mediated synthesis of 20-hydroxyeicosatetraenoic acid (20-HETE) [27,28][27][28]. These multiple actions of the TAL CaSR cause changes in the transluminal voltage that ultimately cause a decrease in paracellular Ca reabsorption. Numerous other actions in kidney mediated by CaSR include increases in TAL PGE2 production [29], changes in aquaporin trafficking and water transport regulation in renal collecting duct [30], decreases in renin secretion by juxtaglomerular cells [31] and stimulation of claudin-14 expression in TAL mediated by a microRNA-signaling pathway downstream from CaSR activation [32].
CaSR protein is also expressed in the gastrointestinal system, bone cells, the nervous system, etc., where these receptors may mediate other Ca-sensitive responses [33]. Among other tissues expressing CaSR are liver cells that stimulate bile flow [34], endothelial cells and vascular smooth muscle cells in many tissues [35] notably in pulmonary arteries [36], pancreatic beta cells [37[37][38],38], and taste buds [39,40,41][39][40][41].

1.3. Amino Acid and Peptide Modulation of CaSR Activity

The sensitivity of the CaSR to Ca is enhanced by a variety of naturally occurring organic molecules of which amino acids were among the earliest to be described; tryptophan, phenylalanine, tyrosine, and histidine are among the most effective modulators of CaSR activity, generally having EC50 concentrations in the range of 1–10 mM [42,43,44][42][43][44]. Zhang et al. [5] discovered a novel derivative of tryptophan, L-1,2,3,4-tetrahydronorharman-3-carboxylic acid, bound to CaSR and having EC50 of approximately 2 µM. In studies of CaSR in taste buds, modulatory effects of small gamma-glutamyl peptides have been the focus, among which the most effective dipeptides were gamma-glutamyl-alanine, gamma-glutamyl valine, and gamma-glutamyl-cysteine [39,40][39][40].
Larger peptides have also been shown to modulate the activity of CaSR, including GSH and GSSG at micromolar and lower concentrations. The study of gamma-glutamyl peptides found that CaSR activity was enhanced by GSH as well as other gamma-glutamyl tripeptides, including gamma-glutamyl-S-methylcysteinylglycine and gamma-glutamylvalylglycine [39[39][40],40], generally exhibiting EC50 values in the micromolar range. Wang et al. [1], studying HEK-293 cells transfected with CaSR and tested in a calcium release assay, showed that the Ca response was enhanced in the presence of either GSH or GSSG. EC50 values were <1 µM for both, compared to an EC50 for phenylalanine of 300 µM in the same assays [1]. Neither CySSG nor CysG were tested.
Of particular note is that both GSH and GSSG produced similar physiological responses, supporting the idea that these responses are mediated by binding to a receptor and are not due to interactions with intracellular redox mechanisms, which might have been an alternative explanation if only one of them had been active. A similar conclusion that the action of glutathione is associated with binding, not redox regulation, has been drawn regarding the male spawning response of the polychaete Nereis succinea, which is also equally well activated by GSH and GSSG [19]. In the case of N. succinea, however, CySSG has also been tested and is effective at eliciting the response at about ten times lower concentration than either GSH or GSSG [19]. Unfortunately, little is known about the structure of the glutathionergic receptor in N. succinea and whether it may be part of the C-family of G-protein coupled receptors from which CaSR evolved in vertebrates. Nevertheless, the binding sites of all three of these glutathionergic compounds to potential receptors is of interest.
Homology modeling to the C class of G-protein coupled receptors [1] and recent crystallographic and cryo-EM studies of CaSR [2,3,4,5][2][3][4][5] have revealed that the modulator binding pocket in the extracellular domain of CaSR is large enough to bind either GSH or GSSG, as well as the natural derivative CySSG) and a related synthetic compound, cysteinyl glutathione (CysGSH). Molecular modeling of the docking of each of these compounds in the binding pocket of CaSR indicate that CySSG and CysGSH may actually bind with up to ten times greater affinity than either GSH or GSSG [1]. CySSG occurs naturally in the circulation and, hypothetically, may be the preferred ligand for modulation of CaSR.

2. Associations of Ca with Glutathionergic Metabolism

Several experiments have examined the association of Ca with GSH metabolism. The rise in GSH synthesis in RAW264.7 macrophage tumor cells in response to gamma rays is Ca dependent [60][45]: GCLC mRNA increased with a similar time course to GSH, a response that was inhibited in cells cultured with 1 mM EGTA (Ca chelator) or BAPTA/AM (intracellular Ca chelator). Coordinate regulation of gene transcription for GCLC, GSS, and other glutathione-regulating genes is mediated by Nrf2, an activator of antioxidant response elements in their 5′-flanking promoter regions [61,62][46][47]. In human keratinocytes, activation of Nrf2 by arsenite was reduced by depleting cells of Ca in Ca-free media [63][48]. Ca-calmodulin inhibition of CK2 kinase activity mediates the response, i.e., low Ca results in higher CK2 activity, which phosphorylates Nrf2, making it more vulnerable to degradation. A treatment that reduced UV-radiation damage in lens tissue decreased the expression of CaSR at the same time that markers of oxidative stress (SOD and “T-AOC,” said to measure total antioxidant content, but is not a direct measurement of glutathione) were increased [64][49].
Changes in glutathione metabolism in liver cells are particularly significant as the liver is the major source of circulating glutathione [65][50]. GSH in hepatocytes was increased by 3.5 mM extracellular Ca compared to 0 mM extracellular Ca [66][51]. In a recent study, ionizing radiation increased liver Ca, accompanied by large decreases in total glutathione and glutathione-regulating enzymes, interpreted as a large relative increase in oxidant status, as compared to antioxidant status [67][52].
These previous studies relating Ca and glutathione have generally interpreted their findings in terms of redox status of cells and, except for the study UV-radiation damage in lens tissue [64][49], have not considered possible roles of CaSR in the mechanisms that might be involved. Nevertheless, evidence exists to indicate that glutathione metabolism may be interactive with calcium signaling and possibly related to extracellular calcium concentration via CaSR.

3. Proposed Role of Glutathionergics in Regulating CaSR Function

The above information can be summarized as follows: First, GSH and its oxidized derivatives CySSG and GSSG are found in mammalian circulation at micromolar concentrations and exhibit changes correlated with age and health. Second, CaSR is found in many tissues, including parathyroid gland, kidney, and bone, where it participates in regulation and utilization of extracellular Ca. Third, amino acids and peptides, including GSH and its derivatives, can sensitize CaSR responses to Ca; in taste buds GSH and related compounds can activate CaSR under ambient Ca conditions. Fourth, consistent with the functional effects of glutathionergics on CaSR, the binding pocket at which amino acids exert their effects on CaSR is large enough to accommodate peptides, including glutathione and its oxidized derivatives. Fifth, extracellular Ca in the same concentration range as is regulated by CaSR in parathyroid, kidney, and bone tissues can modify glutathione synthesis, particularly in hepatocytes, the major source of circulating glutathione.
Given the above observations, researchers therefore propose that circulating glutathionergics (GSH, GSSG, and/or CySSG) bind to and sensitize CaSR to extracellular Ca and thereby participate in the homeostatic regulation of extracellular Ca. A subsidiary hypothesis, based on the physiological principle that homeostatic systems usually have feedback to the source of the regulatory signal, is that extracellular Ca effects on glutathione metabolism in the liver, the major source of circulating glutathionergics, may constitute a feedback mechanism for this hypothesized glutathionergic Ca regulatory mechanism. The association of CySSG changes with age and health and the greater affinity of CySSG for CaSR in model docking simulations may indicate an importance for this derivative of CySSG that has heretofore been overlooked.
This proposed role broadens current views about the functions of glutathione, emphasizing an extracellular receptor-mediated role for glutathionergics, complementary to their well-known intracellular actions regulating the intracellular redox state of cells. This paper highlights the potential biological actions of plasma CySSG and further emphasizes the peptide binding site on CaSR as a potential target the development of drugs that can be used in treating kidney, Parkinson’s and other diseases.

References

  1. Extracellular Calcium Receptor as a Target for Glutathione and Its Derivatives . International Journal of Molecular Sciences. Retrieved 2022-1-20Wang, M.H.; Yao, Y.; Kuang, D.H.; Hampson, D.R. Activation of family C G-protein-coupled receptors by the tripeptide glutathione. J. Biol. Chem. 2006, 281, 8864–8870.
  2. Gao, Y.; Robertson, M.J.; Rahman, S.N.; Seven, A.B.; Zhang, C.S.; Meyerowitz, J.G.; Panova, O.; Hannan, F.M.; Thakker, R.V.; Brauner-Osborne, H.; et al. Asymmetric activation of the calcium-sensing receptor homodimer. Nature 2021, 595, 455–459.
  3. Geng, Y.; Mosyak, L.; Kurinov, I.; Zuo, H.; Sturchler, E.; Cheng, T.C.; Subramanyam, P.; Brown, A.P.; Brennan, S.C.; Mun, H.-C.; et al. Structural mechanism of ligand activation in human calcium-sensing receptor. eLife 2016, 5, e13662.
  4. Ling, S.; Shi, P.; Liu, S.; Meng, X.; Zhou, Y.; Sun, W.; Chang, S.; Zhang, X.; Zhang, L.; Shi, C.; et al. Structural mechanism of cooperative activation of the human calcium-sensing receptor by Ca2+ ions and L-tryptophan. Cell Res. 2021, 31, 383–394.
  5. Zhang, C.; Zhang, T.; Zou, J.; Miller, C.L.; Gorkhali, R.; Yang, J.-Y.; Schilmiller, A.; Wang, S.; Huang, K.; Brown, E.M.; et al. Structural basis for regulation of human calcium-sensing receptor by magnesium ions and an unexpected tryptophan derivative co-agonist. Sci. Adv. 2016, 2, e1600241.
  6. Jocelyn, P.C. The standard redox potential of cysteine-cystine from the thiol-disulfide exchange reaction with glutathione and lipoic acid. Eur. J. Biochem. 1967, 2, 327–331.
  7. Eriksson, S.A.; Mannervik, B. The reduction of the L-cysteine-glutathione mixed disulfide in rat liver. Involvement of an enzyme catalyzing thiol-disulfide interchange. FEBS Lett. 1970, 7, 26–28.
  8. Ormstad, K.; Jones, D.P.; Orrenius, S. Characteristics of glutathione biosynthesis by freshly isolated rat-kidney cells. J. Biol. Chem. 1980, 255, 175–181.
  9. Reed, D.J.; Ellis, W.W.; Meck, R.A. The inhibition of gamma-glutamyl-transferase transpeptidase and glutathione metabolism of isolated rat-kidney cells by L-(alpha-S,5s)-alpha-amino-3-chloro-4, 5-dihydro-5-isoxazoleacetic acid (AT-125, NSC-163501). Biochem. Biophys. Res. Commun. 1980, 94, 1273–1277.
  10. Jones, D.P.; Mody, V.C.; Carlson, J.L.; Lynn, M.J.; Sternberg, P. Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses. Free. Radic. Biol. Med. 2002, 33, 1290–1300.
  11. Kleinman, W.A.; Richie, J.P. Status of glutathione and other thiols and disulfides in human plasma. Biochem. Pharmacol. 2000, 60, 19–29.
  12. Lash, L.H.; Jones, D.P. Distribution of oxidized and reduced forms of glutathione and cysteine in rat plasma. Arch. Biochem. Biophys. 1985, 240, 583–592.
  13. Ookhtens, M.; Mittur, A.V.; Erhart, N.A. Changes in plasma glutathione concentrations, turnover, and disposal in developing rats. Am. J. Physiol. 1994, 266, R979–R988.
  14. Stein, A.F.; Dills, R.L.; Klaassen, C.D. High-performance liquid-chromatographic analysis of glutathione and its thiol and disulfide degradation products. J. Chromatogr. 1986, 381, 259–270.
  15. Walmsley, S.L.; Winn, L.M.; Harrison, M.L.; Uetrecht, J.P.; Wells, P.G. Oxidative stress and thiol depletion in plasma and peripheral blood lymphocytes from HIV-infected patients: Toxicological and pathological implications. Aids 1997, 11, 1689–1697.
  16. Hardege, J.D.; Müller, C.T.; Beckmann, M. A waterborne female sex pheromone in the ragworm Nereis succinia (Annelida, Polychaeta). Polych. Res. 1997, 17, 18–21.
  17. Ram, J.L.; Fei, X.; Danaher, S.M.; Lu, S.; Breithaupt, T.; Hardege, J.D. Finding females: Pheromone-guided reproductive tracking behavior by male Nereis succinea in the marine environment. J. Exp. Biol. 2008, 211, 757–785.
  18. Ram, J.L.; Hardege, J.D. Nereis succinea nuptial behavior: Does size matter? Invertebr. Reprod. Dev. 2005, 48, 89–94.
  19. Ram, J.L.; Müller, C.T.; Beckmann, M.; Hardege, J.D. The spawning pheromone cysteine-glutathione disulfide (‘nereithiones’) arouses a multicomponent nuptial behaviour and electrophysiological activity in Nereis succinea males. FASEB J. 1999, 13, 945–952.
  20. Brown, E.M.; Gamba, G.; Riccardi, D.; Lombardi, M.; Butters, R.; Kifor, O.; Sun, A.; Hediger, M.A.; Lytton, J.; Hebert, S.C. Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid. Nature 1993, 366, 575–580.
  21. Ward, D.T. Calcium receptor-mediated intracellular signalling. Cell Calcium 2004, 35, 217–228.
  22. Conigrave, A.D.; Mun, H.C.; Lok, H.C. Aromatic L-amino acids activate the calcium-sensing receptor. J. Nutr. 2007, 137, 1524S–1527S.
  23. Riccardi, D.; Valenti, G. Localization and function of the renal calcium-sensing receptor. Nat. Rev. Nephrol. 2016, 12, 414–425.
  24. Ortiz, P.A. VAMP-2/3 mediates cAMP-induced translocation of NKCC2 to the apical membrane of the thick ascending limb. J. Am. Soc. Nephrol. 2003, 14, 9A.
  25. Ortiz, P.A. cAMP stimulates NaCl absorption by increasing NKCC2 trafficking to the apical membrane of thick ascending limbs: Role of VAMP-2/3. Hypertension 2004, 44, 500.
  26. Ortiz, P.A. cAMP increases surface expression of NKCC2 in rat thick ascending limbs: Role of VAMP. Am. J. Physiol.-Renal Physiol. 2006, 290, F608–F616.
  27. Wang, W.H.; Lu, M. Effect of arachidonic-acid on activity of the apical K+ channel in the thick ascending limb of the rat-kidney. J. Gen. Physiol. 1995, 106, 727–743.
  28. Wang, W.H.; Lu, M.; Hebert, S.C. Cytochrome P-450 metabolites mediate extracellular Ca2+-induced inhibition of apical K+ channels in the TAL. Am. J. Physiol.-Cell Physiol. 1996, 271, C103–C111.
  29. Wang, D.R.; An, S.J.; Wang, W.H.; McGiff, J.C.; Ferreri, N.R. CaR-mediated COX-2 expression in primary cultured mTAL cells. Am. J. Physiol.-Renal Physiol. 2001, 281, F658–F664.
  30. Ranieri, M.; Di Mise, A.; Centrone, M.; D’Agostino, M.; Tingskov, S.J.; Venneri, M.; Pellegrino, T.; Difonzo, G.; Caponio, F.; Norregaard, R.; et al. Olive Leaf Extract (OLE) impaired vasopressin-induced aquaporin-2 trafficking through the activation of the calcium-sensing receptor. Sci. Rep. 2021, 11, 1–13.
  31. Atchison, D.K.; Beierwaltes, W.H. The influence of extracellular and intracellular calcium on the secretion of renin. Pflügers Arch.-Eur. J. Physiol. 2013, 465, 59–69.
  32. Gong, Y.; Hou, J. Claudin-14 Underlies Ca++-Sensing Receptor–Mediated Ca++Metabolism via NFAT-microRNA–Based Mechanisms. J. Am. Soc. Nephrol. 2014, 25, 745–760.
  33. Brown, E.M.; MacLeod, R.J. Extracellular calcium sensing and extracellular calcium signaling. Physiol. Rev. 2001, 81, 239–297.
  34. Canaff, L.; Petit, J.L.; Kisiel, M.; Watson, P.H.; Gascon-Barre, M.; Hendy, G.N. Extracellular calcium-sensing receptor is expressed in rat hepatocytes—Coupling to intracellular calcium mobilization and stimulation of bile flow. J. Biol. Chem. 2001, 276, 4070–4079.
  35. Guo, Y.J.; Yang, X.; He, J.L.; Liu, J.J.; Yang, S.M.; Dong, H. Important roles of the Ca2+ -sensing receptor in vascular health and disease. Life Sci. 2018, 209, 217–227.
  36. Li, G.-W.; Wang, Q.-S.; Hao, J.-H.; Xing, W.-J.; Guo, J.; Li, H.-Z.; Bai, S.-Z.; Li, H.-X.; Zhang, W.-H.; Yang, B.-F.; et al. The functional expression of extracellular calcium-sensing receptor in rat pulmonary artery smooth muscle cells. J. Biomed. Sci. 2011, 18, 16.
  37. Kitsou-Mylona, I.; Burns, C.J.; Squires, P.E.; Persaud, S.J.; Jones, P.M. A Role for the Extracellular Calcium-Sensing Receptor in Cell-Cell Communication in Pancreatic Islets of Langerhans. Cell. Physiol. Biochem. 2008, 22, 557–566.
  38. Squires, P.E.; Harris, T.E.; Persaud, S.J.; Curtis, S.B.; Buchan, A.M.; Jones, P.M. The extracellular calcium-sensing receptor on human beta-cells negatively modulates insulin secretion. Diabetes 2000, 49, 409–417.
  39. Amino, Y.; Wakabayashi, H.; Akashi, S.; Ishiwatari, Y. Structural analysis and taste evaluation of γ-glutamyl peptides comprising sulfur-containing amino acids. Biosci. Biotechnol. Biochem. 2018, 82, 383–394.
  40. Ohsu, T.; Amino, Y.; Nagasaki, H.; Yamanaka, T.; Takeshita, S.; Hatanaka, T.; Maruyama, Y.; Miyamura, N.; Eto, Y. Involvement of the Calcium-sensing Receptor in Human Taste Perception. J. Biol. Chem. 2010, 285, 1016–1022.
  41. Laffitte, A.; Gibbs, M.; de Alvaro, C.H.; Addison, J.; Lonsdale, Z.N.; Giribaldi, M.G.; Rossignoli, A.; Vennegeerts, T.; Winnig, M.; Klebansky, B.; et al. Kokumi taste perception is functional in a model carnivore, the domestic cat (Felis catus). Sci. Rep. 2021, 11, 1–7.
  42. Conigrave, A.D.; Quinn, S.J.; Brown, E.M. L-Amino acid sensing by the extracellular Ca2+-sensing receptor. Proc. Natl. Acad. Sci. USA 2000, 97, 4814–4819.
  43. Wellendorph, P.; Brauner-Osborne, H. Molecular basis for amino acid sensing by family C G-protein-coupled receptors. Br. J. Pharmacol. 2009, 156, 869–884.
  44. Liu, H.K.; Yi, P.; Zhao, W.J.; Wu, Y.L.; Acher, F.; Pin, J.P.; Liu, J.F.; Rondard, P. Illuminating the allosteric modulation of the calcium-sensing receptor. Proc. Natl. Acad. Sci. USA 2020, 117, 21711–21722.
  45. Teshima, K.; Yamamoto, A.; Yamaoka, K.; Honda, Y.; Honda, S.; Sasaki, T.; Kojima, S. Involvement of calcium ion in elevation of mRNA for gamma-glutamylcysteine synthetase (gamma-GCS) induced by low-dose gamma-rays. Int. J. Radiat. Biol. 2000, 76, 1631–1639.
  46. Pi, J.B.; Zhang, Q.; Woods, C.G.; Wong, V.; Collins, S.; Andersen, M.E. Activation of Nrf2-mediated oxidative stress response in macrophages by hypochlorous acid. Toxicol. Appl. Pharmacol. 2008, 226, 236–243.
  47. Suzuki, T.; Takagi, Y.; Osanai, H.; Li, L.; Takeuchi, M.; Katoh, Y.; Kobayashi, M.; Yamamoto, M. Pi class glutathione S-transferase genes are regulated by Nrf 2 through an evolutionarily conserved regulatory element in zebrafish. Biochem. J. 2005, 388, 65–73.
  48. Pi, J.B.; Bai, Y.S.; Reece, J.M.; Williams, J.; Liu, D.X.; Freeman, M.L.; Fahl, W.E.; Shugar, D.; Liu, J.; Qu, W.; et al. Molecular mechanism of human Nrf2 activation and degradation: Role of sequential phosphorylation by protein kinase CK2. Free Radic. Biol. Med. 2007, 42, 1797–1806.
  49. Ji, Y.H.; Rong, X.F.; Li, D.; Cai, L.; Rao, J.; Lu, Y. Inhibition of Cartilage Acidic Protein 1 Reduces Ultraviolet B Irradiation Induced-Apoptosis through P38 Mitogen-Activated Protein Kinase and Jun Amino-Terminal Kinase Pathways. Cell. Physiol. Biochem. 2016, 39, 2275–2286.
  50. Lauterburg, B.H.; Adams, J.D.; Mitchell, J.R. Hepatic Glutathione Homeostasis in the Rat: Efflux Accounts for Glutathione Turnover. Hepatology 1984, 4, 586–590.
  51. Pascoe, G.A.; Fariss, M.W.; Olafsdottir, K.; Reed, D.J. A role of vitamin E in protection against cell injury—Maintenance of intracellular glutathione precursors and biosynthesis. Eur. J. Biochem. 1987, 166, 241–247.
  52. Abdel-Magied, N.; Elkady, A.A.; Abdel Fattah, S.M. Effect of Low-Level Laser on Some Metals Related to Redox State and Histological Alterations in the Liver and Kidney of Irradiated Rats. Biol. Trace Elem. Res. 2020, 194, 410–422.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/)
ScholarVision Creations
Feedback